- Home
- HRTX vs AMRN Comparison
HRTX vs AMRN Comparison
Compare HRTX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- AMRN
- Stock Information
- Founded
- HRTX 1983
- AMRN 1989
- Country
- HRTX United States
- AMRN Ireland
- Employees
- HRTX N/A
- AMRN N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- HRTX Health Care
- AMRN Health Care
- Exchange
- HRTX Nasdaq
- AMRN Nasdaq
- Market Cap
- HRTX 206.9M
- AMRN 216.0M
- IPO Year
- HRTX 1987
- AMRN 1993
- Fundamental
- Price
- HRTX $1.31
- AMRN $15.33
- Analyst Decision
- HRTX Strong Buy
- AMRN Strong Sell
- Analyst Count
- HRTX 2
- AMRN 1
- Target Price
- HRTX $4.50
- AMRN $12.00
- AVG Volume (30 Days)
- HRTX 2.6M
- AMRN 62.0K
- Earning Date
- HRTX 08-08-2025
- AMRN 10-29-2025
- Dividend Yield
- HRTX N/A
- AMRN N/A
- EPS Growth
- HRTX N/A
- AMRN N/A
- EPS
- HRTX N/A
- AMRN N/A
- Revenue
- HRTX $149,694,000.00
- AMRN $219,361,000.00
- Revenue This Year
- HRTX $10.62
- AMRN N/A
- Revenue Next Year
- HRTX $12.99
- AMRN N/A
- P/E Ratio
- HRTX N/A
- AMRN N/A
- Revenue Growth
- HRTX 9.78
- AMRN N/A
- 52 Week Low
- HRTX $1.04
- AMRN $7.08
- 52 Week High
- HRTX $2.68
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- HRTX 34.65
- AMRN 50.21
- Support Level
- HRTX $1.27
- AMRN $14.64
- Resistance Level
- HRTX $1.42
- AMRN $15.73
- Average True Range (ATR)
- HRTX 0.06
- AMRN 0.50
- MACD
- HRTX 0.02
- AMRN -0.06
- Stochastic Oscillator
- HRTX 33.33
- AMRN 37.10
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.